Obinutuzumab – March 2026

Solution for I.V. infusion 1000 mg in 40 mL,

  • Brand names:
    • Gazyva®
  • Pharmaceutical Company:
    • ROCHE PRODUCTS PTY LTD
  • Condition/Indication: Lupus nephritis
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026